The Experts below are selected from a list of 3540 Experts worldwide ranked by ideXlab platform
Gerrit R J Melles - One of the best experts on this subject based on the ideXlab platform.
-
double bubble Descemet Membrane endothelial keratoplasty unfolding in eyes with deep anterior chambers and anterior chamber intraocular lenses
Cornea, 2020Co-Authors: Jack S Parker, John S Parker, Gerrit R J MellesAbstract:Purpose To describe a standardized technique for Descemet Membrane endothelial keratoplasty unfolding in eyes with deep anterior chambers and anterior chamber intraocular lenses (ACIOLs). Methods Two air bubbles are used simultaneously: the first placed on top of the graft and the second one underneath. Results The 2 bubbles work in concert-the bubble on top props the tissue partially open, while the bubble underneath levitates the graft away from the ACIOL and provides support for subsequent unfolding maneuvers. Conclusions By sandwiching the graft between 2 bubbles, unfolding may proceed away from physical contact with the ACIOL, even in eyes with hyper-deep chambers.
-
are Descemet Membrane ruptures the root cause of corneal hydrops in keratoconic eyes
American Journal of Ophthalmology, 2019Co-Authors: Jack S Parker, Isabel Dapena, Korine Van Dijk, Renuka S Birbal, Silke Oellerich, Gerrit R J MellesAbstract:Purpose To challenge the current consensus on the mechanism causing corneal hydrops in eyes with keratoconus (KC). Design Retrospective, interventional case series. Methods Sixteen eyes of 10 patients with comorbid KC and Fuchs endothelial corneal dystrophy (FECD) underwent uncomplicated Descemet Membrane endothelial keratoplasty (DMEK), and 5 eyes of 5 patients with KC alone underwent Bowman layer (BL) transplantation complicated by inadvertent perforation of the posterior corneal stroma and Descemet Membrane (DM). The presence or absence of hydrops was assessed by intra- and postoperative optical coherence tomography and by slit-lamp biomicroscopy. Results None of the 16 DMEK eyes manifested a hydrops at any time during or after surgery. By contrast, all 5 eyes undergoing BL transplantation complicated by posterior corneal perforation demonstrated a corneal hydrops, evident both intra- and postoperatively. Conclusions In eyes with KC, even the complete removal of DM did not produce a hydrops, whereas a combined defect in DM and the posterior corneal stroma seemed to consistently elicit a typical corneal hydrops.
-
donor tissue preparation for Descemet Membrane endothelial keratoplasty an updated review
Cornea, 2018Co-Authors: Renuka S Birbal, Jessica T Lie, Silke Oellerich, Shameema Sikder, Esther Groeneveldvan A Beek, Gerrit R J MellesAbstract:Purpose:To provide an overview of the current literature on donor tissue preparation for Descemet Membrane endothelial keratoplasty (DMEK).Methods:A comprehensive database search without date restrictions was performed in PubMed and in The Cochrane Library in May, 2017. Keywords included Descemet me
-
prevention and management of Descemet Membrane endothelial keratoplasty complications
Cornea, 2017Co-Authors: Ruth Quilendrino, Isabel Dapena, Lamis Baydoun, Korine Van Dijk, Lisanne Ham, Marina Rodriguezcalvo De Mora, Silke Oellerich, Gerrit R J MellesAbstract:Purpose:To describe Descemet Membrane endothelial keratoplasty (DMEK) complications and strategies for their prevention and management.Methods:Five hundred consecutive eyes with DMEK of 393 patients were reviewed in this retrospective study for intraoperative and postoperative complications up to 2
-
outcome and histopathology of secondary penetrating keratoplasty graft failure managed by Descemet Membrane endothelial keratoplasty
Cornea, 2017Co-Authors: Itay Lavy, Thomas M Muller, Vasilios S. Liarakos, Jack S Parker, Robert M Verdijk, Marieke Bruinsma, Perry S Binder, Gerrit R J MellesAbstract:Purpose:To describe the clinical outcome and histopathology of Descemet Membrane endothelial keratoplasty (DMEK) performed for secondary graft failure after penetrating keratoplasty (PK).Methods:A total of 11 eyes from 10 patients who underwent DMEK for secondary PK graft failure at a tertiary refer
Marianne O Price - One of the best experts on this subject based on the ideXlab platform.
-
Prevention and Management of Pupil Block After Descemet Membrane Endothelial Keratoplasty.
Cornea, 2016Co-Authors: Andres A. Gonzalez, Francis W Price, Marianne O Price, Matthew T. FengAbstract:Purpose:To assess frequency, associations, and outcomes of full air fill after Descemet Membrane endothelial keratoplasty (DMEK).Methods:This retrospective study reviewed 368 consecutive DMEK cases performed to treat Fuchs dystrophy, bullous keratopathy, or failed keratoplasty. Primary outcomes were
-
loteprednol etabonate 0 5 gel vs prednisolone acetate 1 solution after Descemet Membrane endothelial keratoplasty prospective randomized trial
Cornea, 2015Co-Authors: Marianne O Price, Matthew T. Feng, Amanda Scanameo, Francis W PriceAbstract:Purpose:To compare intraocular pressure (IOP) elevation and graft rejection with loteprednol etabonate 0.5% gel and prednisolone acetate 1% solution after Descemet Membrane endothelial keratoplasty (DMEK).Methods:In this prospective, evaluator-masked trial, 167 patients were randomized to lotepredno
-
long term follow up and complications of stripping Descemet Membrane without placement of graft in eyes with fuchs endothelial dystrophy
Cornea, 2014Co-Authors: Juan Arbelaez, Marianne O Price, Francis W PriceAbstract:Purpose:The aim of this study was to describe the clinical course in Fuchs dystrophy where the central Descemet Membrane was removed and not replaced with donor tissue.Methods:Three patients with Fuchs endothelial dystrophy had Descemetorhexis without endothelial keratoplasty.Results:In each case, e
-
randomized comparison of topical prednisolone acetate 1 versus fluorometholone 0 1 in the first year after Descemet Membrane endothelial keratoplasty
Cornea, 2014Co-Authors: Marianne O Price, Francis W Price, Friedrich E Kruse, Bjoern O Bachmann, Theofilos TourtasAbstract:Purpose:The aim of this study was to compare the efficacy and side effects of prednisolone acetate 1% versus fluorometholone 0.1% after Descemet Membrane endothelial keratoplasty (DMEK).Methods:DMEK recipients used prednisolone acetate 1% for 1 month, and they were randomized to either prednisolone
-
Descemet Membrane endothelial keratoplasty donor preparation navigating challenges and improving efficiency
Cornea, 2014Co-Authors: Lawrence R Tenkman, Francis W Price, Marianne O PriceAbstract:Purpose:The aim of this study was to describe the challenges in Descemet Membrane endothelial keratoplasty (DMEK) donor preparations and provide new strategies to achieve success.Methods:A series of 263 consecutive DMEK preparation attempts by a novice surgeon during a corneal fellowship are describ
Francis W Price - One of the best experts on this subject based on the ideXlab platform.
-
Prevention and Management of Pupil Block After Descemet Membrane Endothelial Keratoplasty.
Cornea, 2016Co-Authors: Andres A. Gonzalez, Francis W Price, Marianne O Price, Matthew T. FengAbstract:Purpose:To assess frequency, associations, and outcomes of full air fill after Descemet Membrane endothelial keratoplasty (DMEK).Methods:This retrospective study reviewed 368 consecutive DMEK cases performed to treat Fuchs dystrophy, bullous keratopathy, or failed keratoplasty. Primary outcomes were
-
loteprednol etabonate 0 5 gel vs prednisolone acetate 1 solution after Descemet Membrane endothelial keratoplasty prospective randomized trial
Cornea, 2015Co-Authors: Marianne O Price, Matthew T. Feng, Amanda Scanameo, Francis W PriceAbstract:Purpose:To compare intraocular pressure (IOP) elevation and graft rejection with loteprednol etabonate 0.5% gel and prednisolone acetate 1% solution after Descemet Membrane endothelial keratoplasty (DMEK).Methods:In this prospective, evaluator-masked trial, 167 patients were randomized to lotepredno
-
long term follow up and complications of stripping Descemet Membrane without placement of graft in eyes with fuchs endothelial dystrophy
Cornea, 2014Co-Authors: Juan Arbelaez, Marianne O Price, Francis W PriceAbstract:Purpose:The aim of this study was to describe the clinical course in Fuchs dystrophy where the central Descemet Membrane was removed and not replaced with donor tissue.Methods:Three patients with Fuchs endothelial dystrophy had Descemetorhexis without endothelial keratoplasty.Results:In each case, e
-
randomized comparison of topical prednisolone acetate 1 versus fluorometholone 0 1 in the first year after Descemet Membrane endothelial keratoplasty
Cornea, 2014Co-Authors: Marianne O Price, Francis W Price, Friedrich E Kruse, Bjoern O Bachmann, Theofilos TourtasAbstract:Purpose:The aim of this study was to compare the efficacy and side effects of prednisolone acetate 1% versus fluorometholone 0.1% after Descemet Membrane endothelial keratoplasty (DMEK).Methods:DMEK recipients used prednisolone acetate 1% for 1 month, and they were randomized to either prednisolone
-
Descemet Membrane endothelial keratoplasty donor preparation navigating challenges and improving efficiency
Cornea, 2014Co-Authors: Lawrence R Tenkman, Francis W Price, Marianne O PriceAbstract:Purpose:The aim of this study was to describe the challenges in Descemet Membrane endothelial keratoplasty (DMEK) donor preparations and provide new strategies to achieve success.Methods:A series of 263 consecutive DMEK preparation attempts by a novice surgeon during a corneal fellowship are describ
Lisanne Ham - One of the best experts on this subject based on the ideXlab platform.
-
prevention and management of Descemet Membrane endothelial keratoplasty complications
Cornea, 2017Co-Authors: Ruth Quilendrino, Isabel Dapena, Lamis Baydoun, Korine Van Dijk, Lisanne Ham, Marina Rodriguezcalvo De Mora, Silke Oellerich, Gerrit R J MellesAbstract:Purpose:To describe Descemet Membrane endothelial keratoplasty (DMEK) complications and strategies for their prevention and management.Methods:Five hundred consecutive eyes with DMEK of 393 patients were reviewed in this retrospective study for intraoperative and postoperative complications up to 2
-
rebubbling techniques for graft detachment after Descemet Membrane endothelial keratoplasty
Cornea, 2016Co-Authors: Ester Fernandez Lopez, Isabel Dapena, Lamis Baydoun, Lisanne Ham, Vasilios S. Liarakos, Nadine Gerberhollbach, Gerrit R J MellesAbstract:Purpose:To describe rebubbling techniques in eyes with a visually significant graft detachment after Descemet Membrane endothelial keratoplasty (DMEK).Methods:Retrospective observational analysis at a tertiary referral center. A total of 41 eyes (39 patients) received rebubbling: 39 eyes (37 patient
-
repeat Descemet Membrane endothelial keratoplasty after complicated primary Descemet Membrane endothelial keratoplasty
Ophthalmology, 2015Co-Authors: Lamis Baydoun, Isabel Dapena, Korine Van Dijk, Lisanne Ham, Vasilios S. Liarakos, Fayyaz U Musa, Gerrit R J MellesAbstract:Purpose To describe the clinical outcome and complications of repeat Descemet Membrane endothelial keratoplasty (re-DMEK). Design Retrospective case series study at a tertiary referral center. Participants From a series of 550 consecutive DMEK surgeries with ≥6 months follow-up, 17 eyes underwent re-DMEK for graft detachment after initial DMEK (n = 14) and/or endothelial graft failure (n = 3). The outcomes were compared with an age-matched control group of uncomplicated primary DMEK surgeries. Methods The re-DMEK eyes were evaluated for best-corrected visual acuity (BCVA), densitometry, endothelial cell density (ECD), pachymetry, and intraoperative and postoperative complications. Main Outcome Measures Feasibility and clinical outcome of re-DMEK. Results In all eyes, re-DMEK was uneventful. At 12 months, 12 of 14 eyes (86%) achieved a BCVA of ≥20/40 (≥0.5); 8 of 14 eyes (57%) achieved ≥20/25 (≥0.8), 3 of 14 eyes (21%) achieved ≥20/20 (≥1.0), and 1 eye (7%) achieved 20/17 (1.2); 5 eyes were fitted with a contact lens. Average donor ECD decreased from 2580±173 cells/mm 2 before to 1390±466 cells/mm 2 at 6 months after surgery, and pachymetry from 703±126 μm to 515±39 μm, respectively. No difference in densitometry could be detected between re-DMEK and control eyes ( P = 0.99). Complications after re-DMEK included primary graft failure (n = 1), secondary graft failure (n = 2), graft detachment requiring rebubbling (n = 1), secondary glaucoma (n = 2), cataract (n = 1), and corneal ulcer (n = 1). One eye received tertiary DMEK. Conclusions In the management of persistent graft detachment and graft failure after primary DMEK, re-DMEK proved a feasible procedure. Acceptable BCVA may be achieved, albeit lower than after DMEK in virgin eyes, and some cases may benefit from contact lens fitting. Complications after re-DMEK may be better anticipated than after primary DMEK because graft detachment and graft failure tended to recur, suggesting that intrinsic properties of the host eye play a role in graft adherence and graft failure.
-
Intraocular graft unfolding techniques in Descemet Membrane endothelial keratoplasty.
JAMA ophthalmology, 2013Co-Authors: Vasilios S. Liarakos, Isabel Dapena, Korine Van Dijk, Lisanne Ham, Gerrit R J MellesAbstract:Objective To define various Descemet graft unfolding techniques in Descemet Membrane endothelial keratoplasty. Methods In a retrospective analysis, the surgical videos of 100 consecutive Descemet Membrane endothelial keratoplasty cases with at least 6 months of follow-up were evaluated and categorized. The Descemet graft unfolding methods were categorized into 4 basic techniques and 3 auxiliary techniques. Results All Descemet Membrane endothelial keratoplasty surgical procedures could be completed using (a combination of) 4 Descemet graft unfolding techniques: (1) standardized no-touch graft unfolding using a double roll, (2) carpet unrolling while fixating 1 graft edge (Dirisamer technique), (3) small air bubble–assisted unrolling (Dapena maneuver), (4) the single sliding cannula maneuver. Additional maneuvers included turning over the graft when oriented upside down (flushing); manual graft centration with a cannula; and bubble bumping to unfold peripheral inward folds. In 73% of surgical procedures, technique 1 was used, while a combination of techniques was used in 44% and auxiliary techniques in 62%. None of the techniques showed a correlation with the best-corrected visual acuity, endothelial cell density, or postoperative complication rate (P > .10). Conclusions Descemet Membrane endothelial keratoplasty may be further facilitated by using controlled techniques for unfolding the Descemet graft inside the recipient anterior chamber, either as stand-alone techniques or used in various combinations.
-
recipient endothelium may relate to corneal clearance in Descemet Membrane endothelial transfer
American Journal of Ophthalmology, 2012Co-Authors: Martin Dirisamer, Isabel Dapena, Korine Van Dijk, Lisanne Ham, Ruyin Yeh, Gerrit R J MellesAbstract:Purpose To describe corneal clearance after re-endothelialization of the recipient posterior stroma through Descemet Membrane endothelial transfer (DMET) (ie, a "free-floating" donor Descemet graft in the recipient anterior chamber after Descemetorhexis), in managing corneal endothelial disorders. Design Nonrandomized prospective study at a tertiary referral center. Methods Twelve eyes enrolled in our study, 7 suffering from Fuchs endothelial dystrophy and 5 with bullous keratopathy. The clinical outcome was monitored by biomicroscopy, optical coherence tomography, confocal microscopy, endothelial cell density, and pachymetry measurements. Results All eyes operated on for Fuchs endothelial dystrophy showed corneal clearance, with pachymetry values returning to normal (533 ±47 μm). The denuded recipient stroma re-endothelialized with an average endothelial cell density of 797 (± 743) cells/mm 2 at 6 months after surgery. In contrast, none of the bullous keratopathy eyes showed any improvement throughout the follow-up period. Conclusion DMET may be effective in the management of Fuchs endothelial dystrophy (primarily a Descemet Membrane disorder), but not in bullous keratopathy (primarily an endothelial depletion). Apparently, the indication for surgery (ie, a "dystrophy" vs a "depletion" of recipient endothelial cells) relates to the capacity of the cornea to clear. This suggests that the remaining rim of recipient endothelium (after Descemetorhexis) is involved in the re-endothelialization of the recipient posterior stroma after DMET.
Isabel Dapena - One of the best experts on this subject based on the ideXlab platform.
-
are Descemet Membrane ruptures the root cause of corneal hydrops in keratoconic eyes
American Journal of Ophthalmology, 2019Co-Authors: Jack S Parker, Isabel Dapena, Korine Van Dijk, Renuka S Birbal, Silke Oellerich, Gerrit R J MellesAbstract:Purpose To challenge the current consensus on the mechanism causing corneal hydrops in eyes with keratoconus (KC). Design Retrospective, interventional case series. Methods Sixteen eyes of 10 patients with comorbid KC and Fuchs endothelial corneal dystrophy (FECD) underwent uncomplicated Descemet Membrane endothelial keratoplasty (DMEK), and 5 eyes of 5 patients with KC alone underwent Bowman layer (BL) transplantation complicated by inadvertent perforation of the posterior corneal stroma and Descemet Membrane (DM). The presence or absence of hydrops was assessed by intra- and postoperative optical coherence tomography and by slit-lamp biomicroscopy. Results None of the 16 DMEK eyes manifested a hydrops at any time during or after surgery. By contrast, all 5 eyes undergoing BL transplantation complicated by posterior corneal perforation demonstrated a corneal hydrops, evident both intra- and postoperatively. Conclusions In eyes with KC, even the complete removal of DM did not produce a hydrops, whereas a combined defect in DM and the posterior corneal stroma seemed to consistently elicit a typical corneal hydrops.
-
prevention and management of Descemet Membrane endothelial keratoplasty complications
Cornea, 2017Co-Authors: Ruth Quilendrino, Isabel Dapena, Lamis Baydoun, Korine Van Dijk, Lisanne Ham, Marina Rodriguezcalvo De Mora, Silke Oellerich, Gerrit R J MellesAbstract:Purpose:To describe Descemet Membrane endothelial keratoplasty (DMEK) complications and strategies for their prevention and management.Methods:Five hundred consecutive eyes with DMEK of 393 patients were reviewed in this retrospective study for intraoperative and postoperative complications up to 2
-
case report of quarter Descemet Membrane endothelial keratoplasty for fuchs endothelial dystrophy
Cornea, 2017Co-Authors: Thomas M Muller, Isabel Dapena, Itay Lavy, Lamis Baydoun, Gerrit R J MellesAbstract:Purpose:To describe a further modification of Descemet Membrane endothelial keratoplasty (DMEK), using a quarter of an untrephined full-size donor Descemet Membrane (DM) sheet (“Quarter-DMEK”).Methods:A 58-year-old patient underwent Quarter-DMEK for Fuchs endothelial dystrophy in his pseudophakic ri
-
rebubbling techniques for graft detachment after Descemet Membrane endothelial keratoplasty
Cornea, 2016Co-Authors: Ester Fernandez Lopez, Isabel Dapena, Lamis Baydoun, Lisanne Ham, Vasilios S. Liarakos, Nadine Gerberhollbach, Gerrit R J MellesAbstract:Purpose:To describe rebubbling techniques in eyes with a visually significant graft detachment after Descemet Membrane endothelial keratoplasty (DMEK).Methods:Retrospective observational analysis at a tertiary referral center. A total of 41 eyes (39 patients) received rebubbling: 39 eyes (37 patient
-
repeat Descemet Membrane endothelial keratoplasty after complicated primary Descemet Membrane endothelial keratoplasty
Ophthalmology, 2015Co-Authors: Lamis Baydoun, Isabel Dapena, Korine Van Dijk, Lisanne Ham, Vasilios S. Liarakos, Fayyaz U Musa, Gerrit R J MellesAbstract:Purpose To describe the clinical outcome and complications of repeat Descemet Membrane endothelial keratoplasty (re-DMEK). Design Retrospective case series study at a tertiary referral center. Participants From a series of 550 consecutive DMEK surgeries with ≥6 months follow-up, 17 eyes underwent re-DMEK for graft detachment after initial DMEK (n = 14) and/or endothelial graft failure (n = 3). The outcomes were compared with an age-matched control group of uncomplicated primary DMEK surgeries. Methods The re-DMEK eyes were evaluated for best-corrected visual acuity (BCVA), densitometry, endothelial cell density (ECD), pachymetry, and intraoperative and postoperative complications. Main Outcome Measures Feasibility and clinical outcome of re-DMEK. Results In all eyes, re-DMEK was uneventful. At 12 months, 12 of 14 eyes (86%) achieved a BCVA of ≥20/40 (≥0.5); 8 of 14 eyes (57%) achieved ≥20/25 (≥0.8), 3 of 14 eyes (21%) achieved ≥20/20 (≥1.0), and 1 eye (7%) achieved 20/17 (1.2); 5 eyes were fitted with a contact lens. Average donor ECD decreased from 2580±173 cells/mm 2 before to 1390±466 cells/mm 2 at 6 months after surgery, and pachymetry from 703±126 μm to 515±39 μm, respectively. No difference in densitometry could be detected between re-DMEK and control eyes ( P = 0.99). Complications after re-DMEK included primary graft failure (n = 1), secondary graft failure (n = 2), graft detachment requiring rebubbling (n = 1), secondary glaucoma (n = 2), cataract (n = 1), and corneal ulcer (n = 1). One eye received tertiary DMEK. Conclusions In the management of persistent graft detachment and graft failure after primary DMEK, re-DMEK proved a feasible procedure. Acceptable BCVA may be achieved, albeit lower than after DMEK in virgin eyes, and some cases may benefit from contact lens fitting. Complications after re-DMEK may be better anticipated than after primary DMEK because graft detachment and graft failure tended to recur, suggesting that intrinsic properties of the host eye play a role in graft adherence and graft failure.